APO Research
Talk to an analyst

APO RESEARCH · REPORT

Analgesic Creams

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Analgesic Creams Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchAnalgesic Creams Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Analgesic Creams Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Analgesic Creams Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Analgesic Creams Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Analgesic Creams Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Analgesic Creams market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Analgesic Creams is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Analgesic Creams include Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Huarun 999, GSK, Topical BioMedics and THE PURE SOURCE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Analgesic Creams market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Analgesic Creams and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Analgesic Creams sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Analgesic Creams market size, projected growth trends, production technologies, key applications, and end-use industries.

Analgesic Creams Segment by Company

Sanofi

Johnson & Johnson

Novartis

Mylan

Lingrui

Huarun 999

GSK

Topical BioMedics

THE PURE SOURCE

Teikoku Seiyaku

Qizheng

Mercury Healthcare

Hisamitsu

Endo

Actavis

Analgesic Creams Segment by Type

OTC

RX

Analgesic Creams Segment by Application

Muscle Pain

Arthritis Pain

Analgesic Creams Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic Creams market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Analgesic Creams and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic Creams.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Analgesic Creams market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Analgesic Creams manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Analgesic Creams in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Analgesic Creams in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Analgesic Creams Industry Trends Table 2. Analgesic Creams Industry Drivers Table 3. Analgesic Creams Industry Opportunities and Challenges Table 4. Analgesic Creams Industry Restraints Table 5. Global Analgesic Creams Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Analgesic Creams Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Analgesic Creams Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Analgesic Creams Sales Market Share by Manufacturers Table 9. Global Analgesic Creams Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Analgesic Creams Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Analgesic Creams Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Analgesic Creams Manufacturers, Product Type & Application Table 13. Global Analgesic Creams Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Analgesic Creams by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of OTC Table 17. Major Manufacturers of RX Table 18. Global Analgesic Creams Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Analgesic Creams Sales by Type (2021-2026) & (k units) Table 20. Global Analgesic Creams Sales by Type (2027-2032) & (k units) Table 21. Global Analgesic Creams Sales Market Share by Type (2021-2026) Table 22. Global Analgesic Creams Sales Market Share by Type (2027-2032) Table 23. Global Analgesic Creams Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Analgesic Creams Revenue by Type (2021-2026) & (k units) Table 25. Global Analgesic Creams Revenue by Type (2027-2032) & (k units) Table 26. Global Analgesic Creams Revenue Market Share by Type (2021-2026) Table 27. Global Analgesic Creams Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Muscle Pain Table 29. Major Manufacturers of Arthritis Pain Table 30. Global Analgesic Creams Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Analgesic Creams Sales by Application (2021-2026) & (k units) Table 32. Global Analgesic Creams Sales by Application (2027-2032) & (k units) Table 33. Global Analgesic Creams Sales Market Share by Application (2021-2026) Table 34. Global Analgesic Creams Sales Market Share by Application (2027-2032) Table 35. Global Analgesic Creams Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Analgesic Creams Revenue by Application (2021-2026) & (k units) Table 37. Global Analgesic Creams Revenue by Application (2027-2032) & (k units) Table 38. Global Analgesic Creams Revenue Market Share by Application (2021-2026) Table 39. Global Analgesic Creams Revenue Market Share by Application (2027-2032) Table 40. Global Analgesic Creams Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Analgesic Creams Sales by Region (2021-2026) & (k units) Table 42. Global Analgesic Creams Sales Market Share by Region (2021-2026) Table 43. Global Analgesic Creams Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Analgesic Creams Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Analgesic Creams Sales by Country (2021-2026) & (k units) Table 47. North America Analgesic Creams Sales by Country (2027-2032) & (k units) Table 48. Europe Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Analgesic Creams Sales by Country (2021-2026) & (k units) Table 50. Europe Analgesic Creams Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Analgesic Creams Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Analgesic Creams Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Analgesic Creams Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Analgesic Creams Sales by Country (2027-2032) & (k units) Table 57. Global Analgesic Creams Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Analgesic Creams Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Analgesic Creams Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Analgesic Creams Revenue Market Share by Region (2021-2026) Table 61. Global Analgesic Creams Revenue Market Share by Region (2027-2032) Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sanofi Analgesic Creams Product Portfolio Table 66. Sanofi Recent Development Table 67. Johnson & Johnson Company Information Table 68. Johnson & Johnson Business Overview Table 69. Johnson & Johnson Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Johnson & Johnson Analgesic Creams Product Portfolio Table 71. Johnson & Johnson Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Novartis Analgesic Creams Product Portfolio Table 76. Novartis Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Mylan Analgesic Creams Product Portfolio Table 81. Mylan Recent Development Table 82. Lingrui Company Information Table 83. Lingrui Business Overview Table 84. Lingrui Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Lingrui Analgesic Creams Product Portfolio Table 86. Lingrui Recent Development Table 87. Huarun 999 Company Information Table 88. Huarun 999 Business Overview Table 89. Huarun 999 Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Huarun 999 Analgesic Creams Product Portfolio Table 91. Huarun 999 Recent Development Table 92. GSK Company Information Table 93. GSK Business Overview Table 94. GSK Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. GSK Analgesic Creams Product Portfolio Table 96. GSK Recent Development Table 97. Topical BioMedics Company Information Table 98. Topical BioMedics Business Overview Table 99. Topical BioMedics Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Topical BioMedics Analgesic Creams Product Portfolio Table 101. Topical BioMedics Recent Development Table 102. THE PURE SOURCE Company Information Table 103. THE PURE SOURCE Business Overview Table 104. THE PURE SOURCE Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. THE PURE SOURCE Analgesic Creams Product Portfolio Table 106. THE PURE SOURCE Recent Development Table 107. Teikoku Seiyaku Company Information Table 108. Teikoku Seiyaku Business Overview Table 109. Teikoku Seiyaku Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Teikoku Seiyaku Analgesic Creams Product Portfolio Table 111. Teikoku Seiyaku Recent Development Table 112. Qizheng Company Information Table 113. Qizheng Business Overview Table 114. Qizheng Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Qizheng Analgesic Creams Product Portfolio Table 116. Qizheng Recent Development Table 117. Mercury Healthcare Company Information Table 118. Mercury Healthcare Business Overview Table 119. Mercury Healthcare Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Mercury Healthcare Analgesic Creams Product Portfolio Table 121. Mercury Healthcare Recent Development Table 122. Hisamitsu Company Information Table 123. Hisamitsu Business Overview Table 124. Hisamitsu Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Hisamitsu Analgesic Creams Product Portfolio Table 126. Hisamitsu Recent Development Table 127. Endo Company Information Table 128. Endo Business Overview Table 129. Endo Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Endo Analgesic Creams Product Portfolio Table 131. Endo Recent Development Table 132. Actavis Company Information Table 133. Actavis Business Overview Table 134. Actavis Analgesic Creams Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Actavis Analgesic Creams Product Portfolio Table 136. Actavis Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Analgesic Creams Distributors List Table 140. Analgesic Creams Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Analgesic Creams Product Image Figure 2. Global Analgesic Creams Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Analgesic Creams Market Size (2021-2032) & (US$ Million) Figure 4. Global Analgesic Creams Sales (2021-2032) & (k units) Figure 5. Global Analgesic Creams Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Analgesic Creams Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. OTC Image Figure 9. RX Image Figure 10. Global Analgesic Creams Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Analgesic Creams Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Analgesic Creams Sales Market Share by Type (2021-2032) Figure 13. Global Analgesic Creams Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Analgesic Creams Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Analgesic Creams Revenue Market Share by Type (2021-2032) Figure 16. Muscle Pain Image Figure 17. Arthritis Pain Image Figure 18. Global Analgesic Creams Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Analgesic Creams Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Analgesic Creams Sales Market Share by Application (2021-2032) Figure 21. Global Analgesic Creams Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Analgesic Creams Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Analgesic Creams Revenue Market Share by Application (2021-2032) Figure 24. North America Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Analgesic Creams Sales Market Share by Country (2021-2032) Figure 26. U.S. Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Analgesic Creams Sales Market Share by Country (2021-2032) Figure 31. Germany Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Analgesic Creams Sales Market Share by Country (2021-2032) Figure 38. China Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Analgesic Creams Sales Market Share by Country (2021-2032) Figure 46. Brazil Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Analgesic Creams Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Analgesic Creams Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Analgesic Creams Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Analgesic Creams Revenue (2021-2032) & (US$ Million) Figure 57. North America Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Analgesic Creams Revenue (2021-2032) & (US$ Million) Figure 59. Europe Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Analgesic Creams Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Analgesic Creams Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Analgesic Creams Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Analgesic Creams Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • RX
Applications
  • Muscle Pain
  • Arthritis Pain
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Lingrui
  • Huarun 999
  • GSK
  • Topical BioMedics
  • THE PURE SOURCE
  • Teikoku Seiyaku
  • Qizheng
  • Mercury Healthcare
  • Hisamitsu
  • Endo
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Analgesic Creams Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Analgesic Creams Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Analgesic Creams Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Analgesic Creams Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Analgesic Creams Market Dynamics
  1. 2.1 Analgesic Creams Industry Trends
  2. 2.2 Analgesic Creams Industry Drivers
  3. 2.3 Analgesic Creams Industry Opportunities and Challenges
  4. 2.4 Analgesic Creams Industry Restraints
3 Analgesic Creams Market by Manufacturers
  1. 3.1 Global Analgesic Creams Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Analgesic Creams Sales by Manufacturers (2021-2026)
  3. 3.3 Global Analgesic Creams Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Analgesic Creams Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Analgesic Creams Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Analgesic Creams Manufacturers, Product Type & Application
  7. 3.7 Global Analgesic Creams Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Analgesic Creams Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Analgesic Creams Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Analgesic Creams Tier 1, Tier 2, and Tier 3
4 Analgesic Creams Market by Type
  1. 4.1 Analgesic Creams Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 RX
  4. 4.2 Global Analgesic Creams Sales by Type
  5. 4.2.1 Global Analgesic Creams Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Analgesic Creams Sales by Type (2021-2032)
  7. 4.2.3 Global Analgesic Creams Sales Market Share by Type (2021-2032)
  8. 4.3 Global Analgesic Creams Revenue by Type
  9. 4.3.1 Global Analgesic Creams Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Analgesic Creams Revenue by Type (2021-2032)
  11. 4.3.3 Global Analgesic Creams Revenue Market Share by Type (2021-2032)
5 Analgesic Creams Market by Application
  1. 5.1 Analgesic Creams Application Introduction
  2. 5.1.1 Muscle Pain
  3. 5.1.2 Arthritis Pain
  4. 5.2 Global Analgesic Creams Sales by Application
  5. 5.2.1 Global Analgesic Creams Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Analgesic Creams Sales by Application (2021-2032)
  7. 5.2.3 Global Analgesic Creams Sales Market Share by Application (2021-2032)
  8. 5.3 Global Analgesic Creams Revenue by Application
  9. 5.3.1 Global Analgesic Creams Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Analgesic Creams Revenue by Application (2021-2032)
  11. 5.3.3 Global Analgesic Creams Revenue Market Share by Application (2021-2032)
6 Global Analgesic Creams Sales by Region
  1. 6.1 Global Analgesic Creams Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Analgesic Creams Sales by Region (2021-2032)
  3. 6.2.1 Global Analgesic Creams Sales by Region (2021-2026)
  4. 6.2.2 Global Analgesic Creams Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Analgesic Creams Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Analgesic Creams Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Analgesic Creams Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Analgesic Creams Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Analgesic Creams Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Analgesic Creams Revenue by Region
  1. 7.1 Global Analgesic Creams Revenue by Region
  2. 7.1.1 Global Analgesic Creams Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Analgesic Creams Revenue by Region (2021-2026)
  4. 7.1.3 Global Analgesic Creams Revenue by Region (2027-2032)
  5. 7.1.4 Global Analgesic Creams Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Analgesic Creams Revenue (2021-2032)
  8. 7.2.2 North America Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Analgesic Creams Revenue (2021-2032)
  11. 7.3.2 Europe Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Analgesic Creams Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Analgesic Creams Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Analgesic Creams Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Analgesic Creams Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Analgesic Creams Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Analgesic Creams Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Analgesic Creams Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Lingrui
  26. 8.5.1 Lingrui Company Information
  27. 8.5.2 Lingrui Business Overview
  28. 8.5.3 Lingrui Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lingrui Analgesic Creams Product Portfolio
  30. 8.5.5 Lingrui Recent Developments
  31. 8.6 Huarun 999
  32. 8.6.1 Huarun 999 Company Information
  33. 8.6.2 Huarun 999 Business Overview
  34. 8.6.3 Huarun 999 Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Huarun 999 Analgesic Creams Product Portfolio
  36. 8.6.5 Huarun 999 Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GSK Analgesic Creams Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Topical BioMedics
  44. 8.8.1 Topical BioMedics Company Information
  45. 8.8.2 Topical BioMedics Business Overview
  46. 8.8.3 Topical BioMedics Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Topical BioMedics Analgesic Creams Product Portfolio
  48. 8.8.5 Topical BioMedics Recent Developments
  49. 8.9 THE PURE SOURCE
  50. 8.9.1 THE PURE SOURCE Company Information
  51. 8.9.2 THE PURE SOURCE Business Overview
  52. 8.9.3 THE PURE SOURCE Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 THE PURE SOURCE Analgesic Creams Product Portfolio
  54. 8.9.5 THE PURE SOURCE Recent Developments
  55. 8.10 Teikoku Seiyaku
  56. 8.10.1 Teikoku Seiyaku Company Information
  57. 8.10.2 Teikoku Seiyaku Business Overview
  58. 8.10.3 Teikoku Seiyaku Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Teikoku Seiyaku Analgesic Creams Product Portfolio
  60. 8.10.5 Teikoku Seiyaku Recent Developments
  61. 8.11 Qizheng
  62. 8.11.1 Qizheng Company Information
  63. 8.11.2 Qizheng Business Overview
  64. 8.11.3 Qizheng Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Qizheng Analgesic Creams Product Portfolio
  66. 8.11.5 Qizheng Recent Developments
  67. 8.12 Mercury Healthcare
  68. 8.12.1 Mercury Healthcare Company Information
  69. 8.12.2 Mercury Healthcare Business Overview
  70. 8.12.3 Mercury Healthcare Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mercury Healthcare Analgesic Creams Product Portfolio
  72. 8.12.5 Mercury Healthcare Recent Developments
  73. 8.13 Hisamitsu
  74. 8.13.1 Hisamitsu Company Information
  75. 8.13.2 Hisamitsu Business Overview
  76. 8.13.3 Hisamitsu Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Analgesic Creams Product Portfolio
  78. 8.13.5 Hisamitsu Recent Developments
  79. 8.14 Endo
  80. 8.14.1 Endo Company Information
  81. 8.14.2 Endo Business Overview
  82. 8.14.3 Endo Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Endo Analgesic Creams Product Portfolio
  84. 8.14.5 Endo Recent Developments
  85. 8.15 Actavis
  86. 8.15.1 Actavis Company Information
  87. 8.15.2 Actavis Business Overview
  88. 8.15.3 Actavis Analgesic Creams Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Actavis Analgesic Creams Product Portfolio
  90. 8.15.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Analgesic Creams Value Chain Analysis
  2. 9.1.1 Analgesic Creams Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Analgesic Creams Production Mode & Process
  6. 9.2 Analgesic Creams Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Analgesic Creams Distributors
  9. 9.2.3 Analgesic Creams Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst